Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 13, 2007

NanoInk Receives Patent Rights from Arrowhead Research

  • Arrowhead Research exclusively licensed intellectual property to NanoInk. The patent application covers techniques related to use of surfactants to support NanoInk’s Dip Pen Nanolithography® (DPN®) technology. DPN involves deposition of nanoscale materials onto a substrate.

    Arrowhead’s technology was developed through its sponsored research at the laboratory of Patrick Collier, Ph.D., at the California Institute of Technology.



Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »